Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

ABSTRACT:

SUBMITTER: Ontario Health (Quality) 

PROVIDER: S-EPMC10453298 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature